Search Results 251-260 of 21744 for Ovary

  1. Polyendocrine metabolic ovarian syndrome (PMOS) - Doctors and departments - Mayo Clinic

    Polycystic ovaries, hormone imbalance and irregular periods are telltale signs of polyendocrine metabolic ovarian syndrome. Find out about treatments.

  2. Ovarian cancer - Doctors and departments - Mayo Clinic

    Learn more about cancer of the ovaries, including symptoms and treatments, such as surgery, chemotherapy and targeted therapy.

  3. Ovarian cancer - Doctors and departments - Mayo Clinic

    Learn more about cancer of the ovaries, including symptoms and treatments, such as surgery, chemotherapy and targeted therapy.

  4. Ovarian cancer - Doctors and departments - Mayo Clinic

    Learn more about cancer of the ovaries, including symptoms and treatments, such as surgery, chemotherapy and targeted therapy.

  5. Fertility preservation: Understand your options before cancer treatment - Mayo Clinic

    Ovarian transposition (oophoropexy). During this procedure, the ovaries are surgically repositioned in the pelvis so they're out of the radiation field when ...

  6. Ovarian cancer - Doctors and departments - Mayo Clinic

    Learn more about cancer of the ovaries, including symptoms and treatments, such as surgery, chemotherapy and targeted therapy.

  7. Ovarian cancer - Doctors and departments - Mayo Clinic

    Learn more about cancer of the ovaries, including symptoms and treatments, such as surgery, chemotherapy and targeted therapy.

  8. Ovarian cancer - Doctors and departments - Mayo Clinic

    Learn more about cancer of the ovaries, including symptoms and treatments, such as surgery, chemotherapy and targeted therapy.

  9. Ovarian cancer - Doctors and departments - Mayo Clinic

    Learn more about cancer of the ovaries, including symptoms and treatments, such as surgery, chemotherapy and targeted therapy.

  10. Project 1: Next-Generation TOP1 Inhibition To Treat Ovarian Cancer - Mayo Clinic Research

    Investigators in the Mayo Clinic Ovarian Cancer SPORE are assessing DNA topoisomerase 1 (TOP1) inhibitors to treat ovarian cancer.